The TBI market is advancing through neuroprotective interventions and rehabilitation innovations. Key players including BioDirection, BrainScope, and Neuren Pharmaceuticals are developing novel diagnostic tools and therapeutic agents that improve neurological recovery and functional outcomes. Advancements in biomarker detection and multidisciplinary care approaches are enabling more effective management strategies for this complex neurological condition. Access Market Report: https://shorturl.at/hFCK6